Targeting Therapy of Alzheimer’s and Related Neurodegenerative Diseases

Date: 01-Jun-18 to 04-Jun-18
Location: Bahamas
Alzheimer’s disease (AD) is the most common age-dependent neurodegenerative disease, which affects over 5 million people in the US and over 35 million people worldwide. Currently, only four drugs are approved for alleviating symptoms in AD patients, and no new therapy has been approved for AD since 2003. Other related neurodegenerative diseases such as Parkinson’s disease (PD), Huntington’s disease (HD), and amyotrophic lateral sclerosis (ALS) are also age-dependent and lack effective therapies. Hence, finding cures for AD and other related neurodegenerative diseases is urgent and various approaches should be actively pursued. This planed conference intends to bring leading scientists and clinicians from all over the world to present their unpublished observations or findings to attendees ...

2nd From Carbon-Rich Molecules to Carbon-Based Materials Conference 2018

Date: 07-Jun-18 to 10-Jun-18
Location: Bahamas
This interdisciplinary conference will provide unique “fusion” opportunities for chemists, physicists and engineers having various backgrounds but sharing passion and interests in carbon-only or carbon-rich molecules and carbon-based materials. It will allow a diverse group of scientists from all over the globe to discuss the current challenges, needs and prospects of this quickly-evolving multidisciplinary field. The major focus areas will range from newly designed methods of chemical synthesis, characterization, and structure determination of carbon-rich molecules and carbon-based materials to measurements of their functional properties and investigations into their potential practical applications. The types of carbon-rich molecules include (but are not limited to) π-bowls and π-...

3rd Fibroblast Growth Factors in Development and Repair Conference, 2019

Date: 15-Feb-19 to 18-Feb-19
Location: Bahamas
The roles of Fibroblast Growth Factors (FGF) in stem cell biology, tissue response to injury, in the pathogenesis of genetic and malignant diseases, and as endocrine factors affecting health, disease and aging are rapidly progressing. New papers are regularly being published that have either FGF signalling as a primary focus or that examine FGF interactions with other signalling pathways. Because of the rapid progress in the field of FGFs there remains a real need to have frequent conferences that serve to educate newcomers to the field and allow long-term FGF researchers to catch up on FGF biology in different organ systems or diseases. The 3rd Fibroblast Growth Factor Conference aims to bring together researchers from different disciplines with an interest in FGF biology/biochemistry ...